General Hospital Of Larissa Koutlibaneio And Triantafylleio — Clinical Trial Site

8 Registered trials

4 Currently recruiting

Organisation

General Hospital Of Larissa Koutlibaneio And Triantafylleio

Location

Larissa, Greece

Identifier

ORG-100046169

Address

Tsakalof 1, 412 21, Greece

Departments

Department of Emergencey Medicine
Department of Hematology, Thalassemia and Sickle Cell Disease
Department of Thalassemia
Intensive Care Unit
Ophthalmology Clinic
Thalassemia and SCD Unit
Thalassemia Unit

Clinical trials at this site (8)

Search interface

THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: TH… Pending

2025-525006-37-00 Infection and sepsis 5
Dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international … Recruiting

2023-508153-12-00 Hospital-acquired pneumonia 5 2024-03-26
A research study looking at long-term treatment with etavopivat in people with sickle cell disease or thalassaemia Recruiting

2024-510805-27-00 Sickle Cell Disease and Thalassaemia 5 2025-01-09
An open-label, dose-escalation, dose-finding, and proof-of-concept trial of SP-420 in subjects with transfusion-dependent α- or β-thalassemi… Recruiting

2023-507396-21-00 transfusion-dependent α- or β-thalassemia or low-risk m 4 2023-03-16
Phase 2 Study of Luspatercept in Adults and Adolescents with Alpha (α)-thalassemia Recruiting

2022-502328-35-00 Alpha (α)-thalassemia 4 2023-01-30
This study is a randomized, placebo-controlled, double-blind, multicenter Phase 2/3 study of patients, age 12 to 65 years, with sickle cell … Ended

2024-511535-97-00 sickle cell disease (SCD) 10 2021-12-16
Non-inferiority study between two formulations Brimonidine 0.2%/Timolol 0.5% eye drops solution Ended

2023-507285-24-00 Open angle glaucoma is characterized by increased intra 5 2024-05-31
Research study investigating how well NDec works in people with sickle cell disease Ended

2023-508506-22-00 Sickle cell disease 4 2022-09-22